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Abstract
Ion channels in smooth muscle control coronary vascular tone, but the mechanisms require further 
investigation. The purpose of this study was to evaluate the functional role of KV1 channels on 
porcine coronary blood flow by using the selective antagonist correolide. KV1 channel gene 
transcripts were found in porcine coronary arteries, with KCNA5 (encoding KV1.5) being most 
abundant (P<0.001). Immunohistochemical staining demonstrated KV1.5 protein in the vascular 
smooth muscle layer of both porcine and human coronary arteries, including microvessels. Whole-
cell patch clamp experiments demonstrated significant correolide-sensitive (1–10 µM) current in 
coronary smooth muscle. In vivo studies included direct intracoronary infusion of vehicle or 
correolide into a pressure-clamped left anterior descending artery of healthy swine (n=5 in each 
group) with simultaneous measurement of coronary blood flow. Intracoronary correolide (~0.3–3 
µM targeted plasma concentration) had no effect on heart rate or systemic pressure, but reduced 
coronary blood flow in a dose-dependent manner (P<0.05). Dobutamine (0.3–10 µg/kg/min) 
elicited coronary metabolic vasodilation and intracoronary correolide (3 µM) significantly reduced 
coronary blood flow at any given level of myocardial oxygen consumption (P<0.001). Coronary 
artery occlusions (15 s) elicited reactive hyperemia and correolide (3 µM) reduced the flow 
volume repayment by approximately 30% (P<0.05). Taken together, these data support a major 
role for KV1 channels in modulating baseline coronary vascular tone and perhaps vasodilation in 
response to increased metabolism and transient ischemia.
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Introduction
The limited anaerobic capacity and oxygen extraction reserve of the heart renders the 
myocardium highly dependent on a continuous supply of oxygen to maintain normal cardiac 
function. The ability of the coronary circulation to provide adequate perfusion may be 
challenged by a variety of physiologic factors that modulate microvascular resistance and 
balance oxygen delivery with the underlying myocardial requirements. A number of 
regulatory mechanisms participate in the control of coronary blood flow [7], many of which 
may be affected by disease [37]. Despite decades of research, understanding of the 
mechanisms responsible for regulation of coronary blood flow remains incomplete and there 
are currently more hypotheses than accepted pathways [8].
Significant evidence supports the idea that K+ channels function as critical downstream 
effectors on which multiple signaling pathways converge to modulate coronary vasomotor 
tone [27]. Although multiple types of K+ channels are expressed in coronary vascular 
smooth muscle, voltage-dependent K+ (KV) channels appear to play a predominant role, as 
relatively nonselective inhibition of these channels with 4-aminopyrindine (4-AP) reduces 
baseline coronary blood flow and inhibits local metabolic and ischemic vasodilation [3, 4, 
9]. The precise KV channel subtypes involved have not, however, been clearly defined. 
Given emerging data regarding the role of H2O2 in endothelial and metabolic coronary 
vasodilation [16, 22, 36], recent studies have focused on redox-sensitive KV channels with 
varying conclusions. While data do not support a prominent role for KV7 channels in 
coronary metabolic dilation of rodents or swine [15, 23], genetic deletion of KV1.5 channels 
was found to significantly inhibit the tight coupling of coronary blood flow to myocardial 
metabolism in mice [31]. These findings support an evolving paradigm in which KV1 
channels play requisite roles in controlling coronary blood flow responses to physiological 
and pathophysiological stimuli.
This study tested the hypothesis that KV1 channels are functionally expressed in coronary 
smooth muscle and regulate coronary vascular tone at rest, in response to increases in 
myocardial metabolism, and following transient ischemic episodes (reactive hyperemia). We 
used swine as experimental models and performed quantitative polymerase chain reaction 
(qPCR) to investigate the expression of KCNA genes and immunohistochemistry to 
determine the presence of KV1 channel protein in coronary vascular smooth muscle. The 
contribution of KV1 channels to outward K+ current in isolated coronary smooth muscle 
cells was assessed by patch-clamp electrophysiology with correolide, a selective KV1 
channel inhibitor (1–10 µM). The role of KV1 channels in regulating coronary vascular 
resistance in vivo was examined with intracoronary administration of correolide (10 swine 
were divided into two groups; 5 received vehicle only, while 5 were treated with correolide). 
We determined the effects of correolide on: a) resting coronary blood flow (infused directly 
into the coronary artery to reach 0.3–3 µM in the plasma); b) metabolic dilation evoked by 
dobutamine challenge (0.3–10 µg/kg/min); and c) ischemic dilation in response to a 15 s 
coronary artery occlusion (reactive hyperemia). Correolide has been tested against more than 
100 ion channels and receptors; it blocks all members of the KV1 family, but has no known 
inhibitory effects on other targets [12, 18, 21]. Unique effects of correolide on KV1 channels 
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are due to the presence of a conserved, high specificity binding site in the S5 and S6 
segments of these channels [17].
Methods
All protocols were approved by an Institutional Animal Care and Use Committee and 
performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH 
Pub. No. 85-23, Revised 2011). Human coronary artery samples were obtained with the 
oversight of an Institutional Review Board (protocol # 1306011568).
qPCR analysis of KCNA expression
The left anterior descending (LAD) coronary artery was dissected from the heart and 
cleaned of adipose and connective tissue. Total RNA was isolated using the RNeasy fibrous 
tissue kit (QIAGEN) and stored at −80°C. cDNA synthesis was performed using 1 µg of 
total RNA and the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR was performed using 
SYBR Green Supermix (Bio-Rad). The specificity of PCR amplification products was 
validated by melting-curve analysis. KCNA and GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) primers were designed using Premier Primer 5 software (PREMIER 
Biosoft). Primer sequences and amplicon sizes are given in Table 1. KCNA gene expression 
was normalized to GAPDH and analyzed with Bio-Rad CFX Manager software.
KV1.5 immunohistochemical staining, immunofluorescent localization, and immunoblot
These experiments were performed using an antibody with established reactivity against 
KV1.5 in both swine and humans (APC-150; Alomone Labs; [3]). For conventional 
immunohistochemistry, formalin-fixed, paraffin-embedded sections of swine and human 
coronary arteries were stained in conjunction with the Indiana University 
Immunohistochemistry Laboratory Core (Indiana University Health, Department of 
Pathology). A separate section of human coronary artery was additionally exposed to 
appropriate isotype control to demonstrate specificity of the primary antibody. Slides were 
imaged on an inverted microscope (model 3032, Accu-Scope Inc.) and images captured with 
a digital camera and associated software (DMC2900 and LAS V4.6, Leica Microsystems).
Immunofluorescent staining of the swine coronary microvasculature was performed on 
myocardial samples. Tissue was fixed in 4% paraformaldehyde for 2 hrs on ice, washed in 
phosphate buffered saline, and frozen in Tissue-Tek O.C.T Compound (Sakura Finete) on a 
bed of dry ice and isopentane. Cryosections (8 µm) were cut and O.C.T. was removed by a 5 
min wash in Tris buffered saline (TBS). Tissues were permeabilized in 0.2% Triton X-100 in 
TBS for 5 min, washed, and blocked in 5% horse serum in TBS at room temperature for 1 
hr. Sections were incubated at 37° with the KV1.5 antibody (1:200) and an anti-smooth 
muscle actin antibody conjugated to Cy3 (1:250; C1698, Sigma). Sections without the 
KV1.5 primary antibody served as a negative control. To further verify specificity of the 
KV1.5 immunoreactivity, some sections were incubated with anti-KV1.5 and blocking 
peptide (i.e., control antigen; ~1 µg of peptide/µg of antibody). KV1.5 immunoreactivity was 
detected with anti-rabbit Alexa Fluor 647 (1:4,000; Jackson ImmunoResearch). Slides were 
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mounted in ProLong Gold with DAPI (Invitrogen) and visualized by confocal microscopy 
(Olympus Fluoview FV1000).
Western blots with the KV1.5 antibody were performed on lysates prepared from coronary 
arteries. Arterial segments were homogenized in lysis and extraction buffer containing (mM) 
50 β-glycerophosphate, 0.1 Na3VO4, 2 MgCl2, 1 EGTA, 1 DTT, 0.02 pepstatin, 0.02 
leupeptin, and 1 PMSF, as well as 0.5% Triton X-100 and 0.1 U/ml aprotinin. Lysate (100 µg 
of protein by Bradford assay; Bio-Rad) was loaded on a 4–12% Bis-Tris gel (Life 
Technologies) and electrophoresed. Protein was transferred to nitrocellulose membranes 
overnight at 4 °C and then blocked 1 hr at room temperature with 5% bovine serum albumin. 
Membranes were incubated in primary antibody (1:200) at 4 °C overnight. Membranes were 
washed and placed for 1 hr at room temperature in horseradish peroxidase-linked secondary 
antibody (1:2000 of goat anti-rabbit; Santa Cruz Biotechnology). KV1.5 immunoreactivity 
was visualized with ECL Prime (Amersham).
Patch-clamp electrophysiology
Segments of the swine LAD were enzymatically digested to isolate coronary smooth muscle 
as previously described [9]. Currents were measured at room temperature in conventional 
dialyzed patches. The bath solution contained (mM): 135 NaCl, 5 KCl, 2 MnCl2, 1 MgCl2, 
10 glucose, 10 HEPES, and 5 Tris; pH 7.4. The pipette solution contained (mM): 140 KCl, 3 
Mg-ATP, 1 Na-GTP, 1 EGTA; 10 HEPES, and 5 Tris; pH 7.1. After whole-cell access was 
established, series resistance and membrane capacitance were compensated as fully as 
possible (200B amplifier and pCLAMP software, Axon Instruments).
Surgical preparation
Adult male domestic swine (n = 10) were sedated with telazol, xylazine, and ketamine (5, 
2.5, and 2.5 mg/kg, s.c.) prior to anesthesia with morphine (3 mg/kg, i.m.) and α-chloralose 
(100 mg/kg, i.v.). Once a surgical plane of anesthesia was established, pigs were intubated 
and ventilated with O2-supplemented room air. Catheters were placed into the thoracic aorta 
via the right femoral artery (for blood pressure and heart rate monitoring), into the left 
femoral artery (to draw a supply of blood for the extracorporeal perfusion system), and into 
the right femoral vein (for supplemental anesthetic, heparin, and sodium bicarbonate). The 
heart was accessed via thoracotomy so that the LAD could be isolated and cannulated. The 
animal was heparinized (500 U/kg, iv) and acute in vivo experiments were conducted using 
an extracorporeal pressure-clamped perfusion system. Coronary perfusion pressure was 
maintained at 100 mm Hg by a servo-controlled peristaltic pump throughout the study and 
blood flow was continuously measured by an in-line flow transducer (Transonic Systems). A 
catheter was inserted into the interventricular coronary vein to allow sampling of venous 
blood from the LAD perfusion territory. Blood gas parameters were kept within normal 
physiologic limits through periodic blood gas analyses and appropriate adjustments to 
breathing rate, tidal volume, and/or bicarbonate supplementation. Data were continuously 
recorded using IOX data acquisition software (EMKA Technologies).
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Experimental Protocol
Following coronary cannulation, hemodynamic variables were allowed to stabilize for 15–30 
min before initiation of the protocol. Swine were then randomly assigned to the correolide-
treated or vehicle only group (n = 5 each). Three different protocols were performed to 
examine the role of KV1 channels in the control of coronary blood flow. 1) To examine the 
capacity of KV1 channels to modulate coronary vascular resistance at rest, vehicle (DMSO 
diluted to 10%) or correolide (in 10% DMSO) was continuously infused into the coronary 
perfusion circuit via a syringe pump. In order to obtain the target plasma concentrations of 
correolide (0.3–3 µM), pump infusion rates were calculated based on hematocrit and 
coronary blood flow. 2) The contribution of KV1 channels to metabolic coronary 
vasodilation was assessed with infusion of dobutamine (0.3–10 µg/kg/min, iv) with or 
without intracoronary correolide (3 µM in coronary plasma). 3) The role of KV1 channels in 
ischemic coronary vasodilation was investigated by occluding the coronary perfusion circuit 
for 15 s and then measuring reactive hyperemia with or without intracoronary infusion of 
correolide (3 µM in coronary plasma). Hemodynamic measurements were continuously 
acquired and analyzed when variables stabilized (e.g., 3–5 minutes after an intravenous 
administration of dobutamine).
Statistical analyses
Data are expressed as mean ± standard error for a given number of swine or smooth muscle 
cells. Statistical comparisons were made with t-tests and one or two-way analysis of 
variance (ANOVA) as appropriate. In all statistical test, P < 0.05 was considered statistically 
significant. When significance was detected with ANOVA, a Student-Newman-Keuls 
multiple comparison test was performed to identify differences between groups and 
treatment levels. Data regarding the effects of correolide on the balance between coronary 
blood flow and myocardial metabolism were analyzed by linear regression and analysis of 
covariance (ANCOVA). Volume payment of reactive hyperemia was calculated as area under 
the curve using Prism software (GraphPad Inc.).
Results
PCR analysis of KCNA expression in coronary arteries
KCNA genes (KNCA1…KCNA10) encode KV1 channels (KV1.1…KV1.8). We performed 
qPCR analyses to establish the relative abundance of KCNA transcripts in coronary arteries 
from swine (n = 3; Fig. 1). Primer sequences are provided in Table 1. KCNA expression was 
normalized to a reference gene, GAPDH. We detected the expression of all 8 known KCNA 
gene transcripts, with KCNA5 being most abundant (KCNA5 expression was significantly 
higher than all other KCNA transcripts). KCNA2 was also expressed prominently (KCNA2 
expression was significantly higher than all other KCNA transcripts, except for KCNA5). 
The abundance of all other KCNA genes were lower and statistically indistinguishable (no 
statistically significant differences between the levels of KCNA1, KCNA3, KCNA4, 
KCNA6, KCNA7, or KCNA10).
Goodwill et al. Page 5
Basic Res Cardiol. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Immunohistochemical detection KV1.5 protein in coronary arteries, including resistance-
sized microvessels
Building on the observation that KCNA5 was the most abundant of all KV1 transcripts in 
epicardial coronary samples, we assessed coronary artery expression of KV1.5 protein with 
immunohistochemical techniques. This analysis was performed using a commercially 
available antibody directed against rat KV1.5 with demonstrated reactivity for human KV1.5 
in immunohistochemistry and immunoblots. KV1.5 immunoreactivity was abundant in both 
swine (Fig. 2A) and human (Fig. 2B) coronary artery sections with marked staining of the 
vascular smooth muscle layer. Isotype controls performed with human coronary artery 
samples demonstrated that positive staining was not an artifact (Fig. 2C). Moreover, we 
confirmed that this antibody has appropriate reactivity in swine using Western blot 
techniques (Fig. 2D), as done previously [3].
Since regulation of coronary blood flow is largely controlled by vessels with diameters less 
than 200 µm, we further examined the localization of KV1.5 protein in myocardial sections 
containing resistance-sized microvessels (Fig. 3). Sections of swine myocardium were 
treated with antibodies against KV1.5 and smooth muscle actin (SMA), as well as a nuclear 
stain. Immunoreactivity of the antibodies was detected by fluorescence in separate color 
channels (red and green). Overlaying the color images revealed prominent KV1.5 
immunoreactivity in SMA-positive microvessels (Fig. 3A–C). Pre-adsorbing the KV1.5 
antibody with the antigenic peptide eliminated the detection of KV1.5 immunoreactivity in 
SMA-positive microvessels (Fig. 3D–F). These data indicate that KV1.5 channels are 
expressed in vessels of a caliber appropriate for regulating coronary vascular resistance.
Correolide-sensitive KV1 current in coronary vascular smooth muscle
Based on the presence of KCNA transcripts and KV1.5 protein in epicardial coronaries, 
patch clamp electrophysiology was used to investigate the functional expression of KV1 
channels in coronary smooth muscle cells. Correolide inhibits all members of the KV1 
family, but does not affect other K+ channel types [12, 17, 18, 21]. We measured KV currents 
in coronary smooth muscle cells under conditions that minimize the contribution of other K+ 
channel types (e.g., we lessened the influence of Ca2+-activated and ATP-dependent K+ 
channels by adding a Ca2+ chelator and ATP to the pipette solution). Under these conditions, 
the KV or delayed rectifier K+ current was prominent (i.e., there was time- and voltage-
dependent current that saturated at positive potentials [14, 39]). Correolide inhibited KV 
current in smooth muscle cells from the porcine coronary artery in a concentration-
dependent manner (Fig. 4), indicating that KV1 subunits likely comprise a major portion of 
the channels active under these conditions. Current in the presence of 1 µM correolide was 
reduced >30% at voltages between +20 and +100 mV (P < 0.05; Fig. 4C; n = 4). Current in 
the presence of 10 µM correolide was reduced >80% at voltages between −20 and +100 mV 
(P < 0.05; Fig. 4F; n = 5).
KV1 channels regulate coronary blood flow at the resting heart rate
Our first in vivo experiment was to determine the effect of correolide on coronary blood 
flow at the resting heart rate. Concentration-response experiments showing the effects of 
direct intracoronary infusion of correolide (to targeted plasma concentrations between 0.3 
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and 3 µM; n = 5 correolide-treated swine) are in Fig. 5. Correolide is completely insoluble in 
water and, thus 1:10 DMSO in saline was used as the vehicle. It is our experience that 
DMSO infusions, even very dilute solutions, can elicit dilator responses in the coronary 
circulation; therefore, a second set of swine (n = 5) received intracoronary infusions of this 
vehicle only. Data are presented as a change in flow relative to the baseline within a group 
(vehicle vs. correolide). Vehicle infusions rates were matched to those necessary for 
correolide. Vehicle alone significantly increased coronary blood flow (0.18 ± 0.07 ml/min/g; 
n = 5) at the infusion rates needed to approach concentrations of 1 and 3 µM correolide (Fig. 
5). Initial vehicle studies with infusion rates necessary to obtain coronary plasma 
concentrations of 10 µM correolide increased baseline coronary blood flow > 2-fold. Thus, 
we were unable to perform in vivo studies with concentrations of correolide exceeding 3 
µM. In contrast to vehicle administration, intracoronary infusion of correolide concentration-
dependently decreased coronary blood flow (−0.12 ± 0.03 ml/min/g; Fig. 5). Correolide 
administration significantly reduced coronary blood flow ~25% (i.e., reduced from ~1.0 to 
0.72 ml/min/g with 3 µM correolide; P = 0.01). Because DMSO increased flow and is the 
vehicle for correolide, our experiment likely underestimates the vasoconstriction caused by 
inhibition of KV1 channels. A caveat for the experiment, however, is that coronary blood 
flow decreased as we infused correolide at a constant rate and hence the target concentration 
in coronary plasma was exceeded. To determine the degree to which the target and actual 
plasma concentrations differed, we recalculated and determined that reduced coronary 
plasma flow raised the effective plasma concentrations of correolide to 0.32 ± 0.01, 1.01 
± 0.03, 3.27 ± 0.10 µM. Coronary blood flow data in Fig. 5 are plotted against these 
calculated correolide concentrations. Despite changes in coronary blood flow relative to 
MVO2 (Fig 5), neither vehicle nor correolide infusion significantly altered coronary venous 
PO2 when myocardial oxygen demand was at a resting level (P = 0.16).
Role of KV1 channels in metabolic vasodilation
Our second in vivo experiment was designed to determine the contribution of KV1 channels 
to coronary vasodilation in response to increases in myocardial metabolism (e.g., the 
functional hyperemia that accompanies an increase in heart rate). Hemodynamic data in 
response to dobutamine (0.3–10 µg/kg/min, iv) in the absence and presence of intracoronary 
correolide administration (3 µM in coronary plasma) are presented in Table 2. Dobutamine 
dose-dependently increased systolic blood pressure and heart rate in vehicle-treated swine (n 
= 4; a technical problem with blood samples prevented calculation of myocardial oxygen 
consumption in 1 of the 5 animals intended for this group). Dobutamine increased heart rate, 
systolic, diastolic, and mean blood pressure in correolidetreated swine (n = 5), however, 
blood pressures were significantly lower than the vehicle only group (despite randomization 
of subjects obtained from a common vendor). Regardless of the differences in blood 
pressure, the dobutamine-induced increase myocardial oxygen consumption was not 
different in vehicle- vs. correolide-treated swine (49 ± 8 to 63 ± 9 vs. 44 ± 7 to 73 ± 7 µl 
O2/min/g; P = 0.97). This is likely due to the fact that heart rate is a more important 
determinant of myocardial oxygen consumption than afterload [10]. The effect of KV1 
channel inhibition on metabolic coronary vasodilation was examined by analyzing the 
relationship between coronary blood flow and myocardial oxygen consumption (Fig. 6A). 
Linear regression determined that the slope of this relationship was not different in the 
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vehicle and correolide groups (P = 0.34). ANCOVA revealed that correolide markedly 
reduced coronary blood flow relative to myocardial oxygen consumption across the 
dobutamine concentration range (P < 0.001; i.e., correolide shifts the relationship down in a 
parallel manner). Examining coronary venous PO2 revealed interesting effects of correolide 
on the balance between myocardial oxygen supply and demand (Fig. 6B). In the vehicle 
only group, coronary venous PO2 declined as myocardial oxygen consumption increased. In 
contrast, in the correolide-treated group, coronary venous PO2 was lower at rest and did not 
decline further as myocardial oxygen consumption increased (P < 0.05).
KV1 channels function in ischemic vasodilation
Our final in vivo experiment was designed to determine whether KV1 channels play a role in 
coronary reactive hyperemia (i.e., vasodilation in response to a transient myocardial 
ischemia). Hyperemic responses were elicited by occluding the arterial perfusion cannula for 
15 s. Coronary blood flow responses were measured under control conditions (in swine 
treated with vehicle only; n = 5) and during infusion of correolide at a plasma concentration 
of 3 µM (n = 5 different swine). Average reactive hyperemia responses are shown in Fig. 7. 
Correolide reduced baseline coronary blood flow by ~25% (1.06 ± 0.28 to 0.79 ± 0.19 
ml/min/g; P < 0.05). Inhibition of KV1 channels did not affect peak hyperemia (~3.5 
ml/min/g; P = 0.29), but correolide significantly decreased the overall volume of repayment 
by ~35% (1.86 ± 0.39 to 1.21 ± 0.28 ml/g; P < 0.05).
Discussion
We used an integrative and complementary set of in vitro and in vivo approaches to evaluate 
the role of KV1 channels in the regulation of coronary blood flow in swine. We tested the 
hypothesis that KV1 channels are functionally expressed in coronary smooth muscle and 
regulate coronary vascular tone at rest, in response to increases in myocardial metabolism, 
and following transient ischemic episodes (reactive hyperemia). All 8 known KCNA 
transcripts were expressed in swine coronary arteries, with KCNA5 (encoding KV1.5) being 
most abundant. Immunohistochemistry experiments showed that KV1.5 channel protein was 
expressed in the medial (smooth muscle) layer of human and swine coronary arteries – 
including resistance vessels, which regulate flow. In porcine coronary smooth muscle, the 
KV1-selective inhibitor correolide blocked the majority of K+ current, demonstrating that 
KV1 subunits are functionally expressed in abundance. KV1 channels maintain baseline 
coronary vasomotor tone, as selective inhibition of these channels with correolide reduced 
coronary blood flow ~25% at the resting heart rate. Correolide significantly depressed the 
relationship between coronary blood flow and myocardial oxygen consumption, indicating 
that KV1 channels may participate in functional hyperemia. KV1 channels may also function 
in ischemic dilation, as correolide reduced the overall volume of flow repayment in response 
to a 15 s coronary occlusion (i.e., KV1 channels regulate the duration of coronary reactive 
hyperemia). Alternative interpretations could be that KV1 channels have a tonic role in the 
regulation of coronary vascular tone and that inhibiting them results in a parallel shift in the 
relationship between coronary blood flow and cardiac metabolism and no impairment in 
peak ischemic vasodilation. These findings support the idea that KV1 channels are important 
end-effectors regulating coronary microvascular resistance.
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Molecular and functional expression of KV1 channels in coronary arteries
KCNA gene and KV1 channel expression in swine coronary arteries confirm and extend 
prior studies demonstrating the presence of multiple KCNA transcripts and KV1 channel 
proteins in coronary arteries from mice, rats, dogs, and swine [3, 9, 13, 30, 31]. Expression 
of other KV channel isoforms (e.g., KV3 and KV7 families) has also been documented in 
coronary arteries of mice, rats, and swine [3, 15, 19, 20, 23, 24]. Correolide blocked a 
majority of the K+ current in smooth muscle cells; therefore, it is reasonable to conclude that 
channels composed of KV1 channel subunits produce a significant portion of the delayed 
rectifier K+ current. The substantial inhibitory effect of correolide agrees well with what we 
observed previously in canine coronary smooth muscle cells [9]. Further, the delayed 
rectifier K+ currents of smooth muscle cells from the coronary arteries of dogs, pigs, and 
humans have many biophysical and pharmacological similarities [9, 14], suggesting that 
KV1 subunits form at least a portion of the channels. This idea is supported by the detection 
of KV1.5 protein expression in the coronary smooth muscle of swine and humans, including 
resistance vessels.
Role of KV1 channels in metabolic coronary vasodilation
Identifying the mechanisms coupling coronary blood flow to myocardial metabolism has 
been a central quest in coronary physiology for over 50 years. There is a growing body of 
evidence supporting KV channels as critical modulators in the local metabolic control of 
coronary blood flow [3, 31, 36]. Other K+ channels, such as inwardly rectifying K+ channels 
(Kir) may also be important [11], but were not studied here. Non-selective inhibition of KV 
channels with 4-AP dose-dependently reduces resting coronary blood flow and decreases the 
balance between myocardial oxygen delivery and metabolism in response to cardiac pacing, 
norepinephrine, and exercise [3, 36]. Data from this study may support a role for KV1 
channels in coronary metabolic vasodilation [31], but the mostly parallel downward shift in 
the relationship between coronary blood flow and myocardial oxygen consumption caused 
by correolide may be indicative of a tonic role. Intuitively, one would expect a similar 
parallel downward shift in the relationship between coronary venous PO2 and myocardial 
oxygen consumption; however, no such shift was detectable statistically. This may be due 
factors such as the elevated coronary venous PO2 typically observed in cannulated 
preparations and the effect of DMSO to elicit coronary vasodilation. The role of KV1 
channels in regulating the balance between coronary flow and myocardial metabolism is 
supported by the modest reduction in coronary venous PO2 at lower levels of myocardial 
demand (Fig 6B). Coronary venous PO2 was higher in vehicle-treated animals relative to 
correolide-treated counterparts at the lowest infusion rates (42 ± 4 vs. 35 ± 2 mmHg). This 
vehicle-induced overperfusion became less significant with increasing metabolic demand. 
However, owing to lower coronary venous PO2 values relative to myocardial oxygen 
consumption at low infusion rates, the slope of the relationship is much flatter in correolide-
treated animals than is found in the vehicle only controls (Fig 6B).
A recent study demonstrated a much more profound reduction in the slope of the 
relationship between coronary flow and cardiac double product (index of myocardial 
metabolism) in KV1.5 knockout mice during norepinephrine administration [31]. 
Importantly, this phenotype was associated with significant myocardial hypoxia and was 
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rescued by smooth muscle-specific expression of KV1.5 in the global knockouts. It should 
be recognized that while the knockout mouse model provides compelling evidence with 
genetic targeting of specific channels, compensatory upregulation of other KV channel 
subtypes and marked differences in the underlying cardiovascular phenotype of mice (heart 
rate >500 beats/min; coronary blood flow >10 fold higher than large animal models or 
humans) must be taken into account. We were unable to use higher concentrations of 
correolide in vivo to further investigate coronary metabolic vasodilation, as effects of vehicle 
made higher dose rates of impractical. Together, these findings collectively support a 
prominent role for KV1 channels as crucial end-effectors in the coronary circulation of mice, 
dogs, and swine.
We did not focus on identifying specific factors that converge on Kv1 channels in this 
investigation. However, prior studies have demonstrated that putative dilators such as 
adenosine, nitric oxide, prostacyclin, and H2O2 mediate coronary vasodilation, at least in 
part, via 4-AP-sensitive KV channels. Our prior study also established that correolide 
significantly reduces dilation of isolated coronary arterioles to adenosine and sodium 
nitroprusside [9], indicating that KV1 channels are the targets of known coronary 
vasodilators. There are likely numerous endothelial and metabolic factors that converge on 
KV1 channel subtypes to modulate coronary vascular tone, including H2O2 [34–36]. 
Alternatively, it is well established that direct β-adrenoceptor activation contributes to the 
control of coronary blood flow during increases in myocardial metabolism [29]. Thus, it is 
possible that increases in coronary flow in response to catecholamine administration (or 
elevated sympathetic tone and plasma catecholamine concentrations with exercise) induce 
smooth muscle relaxation via a cAMP-protein kinase dependent activation of KV1 channels 
[1, 2]. Numerous additional studies will be needed to examine the precise KV channel 
subtypes responsible for eliciting dilation to these, as well as other, putative factors.
Role of KV1 channels in ischemic coronary vasodilation
Coronary dilation in response to myocardial ischemia is a critical mechanism that sustains 
oxygen delivery to the heart to mitigate ischemic injury and infarction. A well accepted 
experimental approach to examine ischemic coronary vasodilation is to measure coronary 
blood flow responses following a brief coronary artery occlusion. This reactive hyperemia 
has been attributed to a variety of mechanisms including myogenic, endothelial, and local 
metabolic factors [38]. Prior work from our laboratory support relatively modest roles for 
adenosine and nitric oxide, with a more pronounced contribution of KV and KATP channels 
[5, 9]. The extent to which KV1 channels contribute to coronary reactive hyperemia, 
however, has not been previously investigated.
Inhibition of KV1 channels with correolide significantly decreased overall repayment of flow 
debt. This suggests that factors produced during acute myocardial ischemia elicit 
vasodilation, in part, via KV1 channels. This overall effect of correolide is similar to our 
earlier findings in dogs with 4-AP, which diminished baseline flow and the overall volume 
of repayment [9]. In contrast, we recently documented that inhibition of KV7 channels with 
linopirdine had no effect on coronary reactive hyperemic responses in swine [15]. Although 
correolide diminished the duration of reactive hyperemia, it is important to point out that 
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peak hyperemia was unaffected by the correolide, which could be interpreted as no role for 
KV1 channels. Peak responses increase with the duration of the occlusion up to ~15–30 s, 
indicating that maximal vasodilator capacity is reached within 30 s of ischemia. Thus, one 
could conclude that KV1 channels do not contribute to ischemic coronary vasodilation. 
However, we argue that the reduction in volume of repayment (duration of ischemic 
vasodilation) supports a role for these channels, as the hyperemic response is estimated to 
provide only ~80% of the necessary oxygen repayment incurred during the flow deficit.
Implications and conclusions
KV1 channels are functionally expressed and contribute to the regulation of coronary 
microvascular resistance at rest, during β-adrenoceptor activation, and myocardial ischemia. 
We propose that KV1.5 channels are likely to be the predominant subtype, however, the lack 
of specific pharmacologic agents to activate or inhibit KV1.5 channels currently prevents 
direct examination of this hypothesis in our large animal preparation. While these studies 
were performed in normal healthy swine, prior evidence from our laboratory [3] and others 
[25, 26, 28] indicates that KV channel function is impaired by obesity and/or diabetes 
mellitus. Furthermore, coronary microvascular dysfunction has been linked with several 
other pathologic conditions including hypertension, Takotsubo cardiomyopathy, heart failure 
with preserved ejection fraction, and no re-flow phenomenon [6, 32, 33]. Thus, further 
examination of the role of coronary KV1 channels is likely to provide much needed insight 
in to physiologic and pathophysiologic mechanisms of coronary flow regulation.
Acknowledgments
This study was supported by U01HL118738 (G. Kassab) and R01HL11760 (J. Tune). Dr. Goodwill was supported 
by American Heart Association 13POST1681001813. Ms. Noblet and Mr. Sassoon were supported by TL1 
TR000162 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical 
and Translational Sciences Award.
References
1. Aiello EA, Malcolm AT, Walsh MP, Cole WC. Beta-adrenoceptor activation and PKA regulate 
delayed rectifier K+ channels of vascular smooth muscle cells. Am J Physiol. 1998; 275:H448–
H459. [PubMed: 9683432] 
2. Aiello EA, Walsh MP, Cole WC. Phosphorylation by protein kinase A enhances delayed rectifier K+ 
current in rabbit vascular smooth muscle cells. Am J Physiol. 1995; 268:H926–H934. [PubMed: 
7864221] 
3. Berwick ZC, Dick GM, Moberly SP, Kohr MC, Sturek M, Tune JD. Contribution of voltage-
dependent K channels to metabolic control of coronary blood flow. J Mol Cell Cardiol. 2012; 
52:912–919. [PubMed: 21771599] 
4. Berwick ZC, Moberly SP, Kohr MC, Morrical EB, Kurian MM, Dick GM, Tune JD. Contribution of 
voltage-dependent K+ and Ca2+ channels to coronary pressure-flow autoregulation. Basic Res 
Cardiol. 2012; 107:264. [PubMed: 22466959] 
5. Berwick ZC, Payne GA, Lynch B, Dick GM, Sturek M, Tune JD. Contribution of adenosine A(2A) 
and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels. 
Microcirculation. 2010; 17:600–607. [PubMed: 21044214] 
6. Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and 
functional assessment. Nat Rev Cardiol. 2015; 12:48–62. [PubMed: 25311229] 
7. DeFily DV, Chilian WM. Coronary microcirculation: autoregulation and metabolic control. Basic 
Res Cardiol. 1995; 90:112–118. [PubMed: 7646415] 
Goodwill et al. Page 11
Basic Res Cardiol. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
8. Deussen A, Brand M, Pexa A, Weichsel J. Metabolic coronary flow regulation--current concepts. 
Basic Res Cardiol. 2006; 101:453–464. [PubMed: 16944360] 
9. Dick GM, Bratz IN, Borbouse L, Payne GA, Dincer UD, Knudson JD, Rogers PA, Tune JD. 
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary 
circulation. Am J Physiol Heart Circ Physiol. 2008; 294:H2371–H2381. [PubMed: 18375717] 
10. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiological reviews. 
2008; 88:1009–1086. doi:88/3/1009 [pii] 10.1152/physrev.00045.2006. [PubMed: 18626066] 
11. Fedele F, Mancone M, Chilian WM, Severino P, Canali E, Logan S, De Marchis ML, Volterrani M, 
Palmirotta R, Guadagni F. Role of genetic polymorphisms of ion channels in the pathophysiology 
of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol. 2013; 
108:387. [PubMed: 24068186] 
12. Felix JP, Bugianesi RM, Schmalhofer WA, Borris R, Goetz MA, Hensens OD, Bao JM, Kayser F, 
Parsons WH, Rupprecht K, Garcia ML, Kaczorowski GJ, Slaughter RS. Identification and 
biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-
gated potassium channel, Kv1.3. Biochemistry. 1999; 38:4922–4930. [PubMed: 10213593] 
13. Gautier M, Hyvelin JM, de Crescenzo V, Eder V, Bonnet P. Heterogeneous KV1 function and 
expression in coronary myocytes from right and left ventricles in rats. Am J Physiol Heart Circ 
Physiol. 2007; 292:H475–H482. [PubMed: 16731637] 
14. Gollasch M, Ried C, Bychkov R, Luft FC, Haller H. K+ currents in human coronary artery vascular 
smooth muscle cells. Circ Res. 1996; 78:676–688. [PubMed: 8635225] 
15. Goodwill AG, Fu L, Noblet JN, Casalini ED, Sassoon D, Berwick ZC, Kassab GS, Tune JD, Dick 
GM. KV7 channels contribute to paracrine, but not metabolic or ischemic, regulation of coronary 
vascular reactivity in swine. Am J Physiol Heart Circ Physiol. 2016; 310:H693–H704. [PubMed: 
26825518] 
16. Gutterman DD, Miura H, Liu Y. Redox modulation of vascular tone: focus of potassium channel 
mechanisms of dilation. Arterioscler Thromb Vasc Biol. 2005; 25:671–678. [PubMed: 15705931] 
17. Hanner M, Green B, Gao YD, Schmalhofer WA, Matyskiela M, Durand DJ, Felix JP, Linde AR, 
Bordallo C, Kaczorowski GJ, Kohler M, Garcia ML. Binding of correolide to the K(v)1.3 
potassium channel: characterization of the binding domain by site-directed mutagenesis. 
Biochemistry. 2001; 40:11687–11697. [PubMed: 11570869] 
18. Hanner M, Schmalhofer WA, Green B, Bordallo C, Liu J, Slaughter RS, Kaczorowski GJ, Garcia 
ML. Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high 
affinity interaction. J Biol Chem. 1999; 274:25237–25244. [PubMed: 10464244] 
19. Heaps CL, Jeffery EC, Laine GA, Price EM, Bowles DK. Effects of exercise training and 
hypercholesterolemia on adenosine-activation of voltage-dependent K+ channels in coronary 
arterioles. J Appl Physiol. 2008
20. Hedegaard ER, Nielsen BD, Kun A, Hughes AD, Kroigaard C, Mogensen S, Matchkov VV, 
Frobert O, Simonsen U. KV 7 channels are involved in hypoxia-induced vasodilatation of porcine 
coronary arteries. Br J Pharmacol. 2014; 171:69–82. [PubMed: 24111896] 
21. Kaczorowski GJ, Garcia ML. Pharmacology of voltage-gated and calcium-activated potassium 
channels. Curr Opin Chem Biol. 1999; 3:448–458. [PubMed: 10419851] 
22. Kang PT, Chen CL, Ohanyan V, Luther DJ, Meszaros JG, Chilian WM, Chen YR. Overexpressing 
superoxide dismutase 2 induces a supernormal cardiac function by enhancing redox-dependent 
mitochondrial function and metabolic dilation. J Mol Cell Cardiol. 2015; 88:14–28. [PubMed: 
26374996] 
23. Khanamiri S, Soltysinska E, Jepps TA, Bentzen BH, Chadha PS, Schmitt N, Greenwood IA, 
Olesen SP. Contribution of Kv7 channels to basal coronary flow and active response to ischemia. 
Hypertension. 2013; 62:1090–1097. [PubMed: 24082059] 
24. Lee S, Yang Y, Tanner MA, Li M, Hill MA. Heterogeneity in Kv7 channel function in the cerebral 
and coronary circulation. Microcirculation. 2015; 22:109–121. [PubMed: 25476662] 
25. Li H, Chai Q, Gutterman DD, Liu Y. Elevated glucose impairs cAMP-mediated dilation by 
reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ 
Physiol. 2003; 285:H1213–H1219. [PubMed: 12763748] 
Goodwill et al. Page 12
Basic Res Cardiol. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
26. Li H, Gutterman DD, Rusch NJ, Bubolz A, Liu Y. Nitration and functional loss of voltage-gated K
+
 channels in rat coronary microvessels exposed to high glucose. Diabetes. 2004; 53:2436–2442. 
doi:53/9/2436 [pii]. [PubMed: 15331556] 
27. Liu Y, Gutterman DD. Vascular control in humans: focus on the coronary microcirculation. Basic 
Res Cardiol. 2009; 104:211–227. [PubMed: 19190954] 
28. Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K+ channel current 
in rat small coronary arteries. Circ Res. 2001; 89:146–152. [PubMed: 11463721] 
29. Miyashiro JK, Feigl EO. Feedforward control of coronary blood flow via coronary beta-receptor 
stimulation. Circ Res. 1993; 73:252–263. [PubMed: 8392446] 
30. Mokelke EA, Hu Q, Song M, Toro L, Reddy HK, Sturek M. Altered functional coupling of 
coronary K+ channels in diabetic dyslipidemic pigs is prevented by exercise. J Appl Physiol. 2003; 
95:1179–1193. [PubMed: 12777409] 
31. Ohanyan V, Yin L, Bardakjian R, Kolz C, Enrick M, Hakobyan T, Kmetz JG, Bratz I, Luli J, 
Nagane M, Khan N, Hou H, Kuppusamy P, Graham J, Fu FS, Janota D, Oyewumi MO, Logan SJ, 
Lindner JR, Chilian WM. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation. Circ 
Res. 2015
32. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: 
comorbidities drive myocardial dysfunction and remodeling through coronary microvascular 
endothelial inflammation. J Am Coll Cardiol. 2013; 62:263–271. [PubMed: 23684677] 
33. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, 
Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van 
Royen N. Magnetic resonance imaging-defined areas of microvascular obstruction after acute 
myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013; 
34:2346–2353. [PubMed: 23594591] 
34. Rogers PA, Chilian WM, Bratz IN, Bryan RM Jr, Dick GM. H2O2 activates redox- and 4-
aminopyridine-sensitive KV channels in coronary vascular smooth muscle. Am J Physiol Heart 
Circ Physiol. 2007; 292:H1404–H1411. doi:00696.2006 [pii] 10.1152/ajpheart.00696.2006. 
[PubMed: 17071731] 
35. Rogers PA, Dick GM, Knudson JD, Focardi M, Bratz IN, Swafford AN Jr, Saitoh S, Tune JD, 
Chilian WM. H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-
aminopyridine-sensitive K+ channels. Am J Physiol Heart Circ Physiol. 2006; 291:H2473–H2482. 
doi:00172.2006 [pii] 10.1152/ajpheart.00172.2006. [PubMed: 16751285] 
36. Saitoh S, Zhang C, Tune JD, Potter B, Kiyooka T, Rogers PA, Knudson JD, Dick GM, Swafford A, 
Chilian WM. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to 
coronary blood flow. Arterioscler Thromb Vasc Biol. 2006; 26:2614–2621. [PubMed: 17023676] 
37. Setty S, Sun W, Tune JD. Coronary blood flow regulation in the prediabetic metabolic syndrome. 
Basic Res Cardiol. 2003; 98:416–423. [PubMed: 14556087] 
38. Tune JD. Coronary Circulation. Colloquium Series on Integrated Systems Physiology: From 
Molecule to Function. 2014; 6:1–189.
39. Volk KA, Matsuda JJ, Shibata EF. A voltage-dependent potassium current in rabbit coronary artery 
smooth muscle cells. J Physiol. 1991; 439:751–768. [PubMed: 1910087] 
Goodwill et al. Page 13
Basic Res Cardiol. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. KCNA gene transcripts are expressed in swine coronary arteries
Group data (samples from n = 3 pigs) for qPCR are shown. KCNA transcripts are 
normalized to the abundance of a reference gene, GAPDH. KCNA2 and KCNA5 were the 
most abundant transcripts. Asterisk indicates that the KCNA5 value is higher than that for all 
other KCNA isoforms, including KCNA2. Dagger indicates that the KCNA2 value is higher 
than all other KCNA isoforms, excluding KCNA5.
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Fig. 2. KV1.5 channel protein is expressed in swine and human coronary arteries
Coronary artery sections from swine and humans are shown. In panels A (swine) and B 
(human), coronary arteries were stained for KV1.5 (brown indicates positive 
immunoreactivity). A negative control in human tissue is shown in panel C. Panel D 
contains a Western blot performed on proteins extracted from the swine coronary artery. 
KV1.5 immunoreactivity appears at approximately 67 kDa.
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Fig. 3. KV1.5 channel protein is expressed in the coronary microcirculation
Representative immunofluorescence experiments from swine myocardium are shown. Panel 
A contains line scans of the intensity of green (KV1.5) and red (smooth muscle actin, SMA) 
fluorescence across a section of heart muscle containing resistance-sized vessels (Panel B). 
Note the spikes in KV1.5 immunofluorescence intensity that overlap with the peaks of SMA. 
Panel C shows the green and blue (nuclear) channels from Panel B. Panel D contains line 
scans of the intensity of green (KV1.5) and red (SMA) fluorescence across a section of 
myocardium stained with KV1.5 antibody pre-adsorbed to its antigenic peptide (Panel E; the 
green and blue channels are shown in Panel F). Note the lack of green immunofluorescence 
in the red peaks. Panel G contains line scans of the intensity of green (KV1.5) and red 
(SMA) fluorescence across a section of heart incubated without the primary KV1.5 antibody 
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(Panel H; the green and blue channels are shown in Panel I). Note the lack of green 
immunofluorescence.
Goodwill et al. Page 17
Basic Res Cardiol. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 4. Correolide inhibits KV1 current in swine coronary smooth muscle cells
Patch clamp recordings from representative cells are shown for experiments with 1 and 10 
µM correolide. Depolarization elicited time- and voltage-dependent currents (panel A; the 
voltage template is shown below the control trace). Correolide (1 µM) inhibited current 
approximately 30% (panel B). Panel C contains group data (n = 4 cells) for the current-
voltage relationship before and after 1 µM correolide. Current is normalized to membrane 
capacitance, an index of cell size (P < 0.05 for effect of correolide on currents at membrane 
potentials between +20 and +100 mV). Panels D and E show the effect of 10 µM correolide. 
This higher concentration of correolide inhibited the majority of whole-cell current in 
coronary vascular smooth muscle cells. Panel F contains group data (n = 5 cells) for the 
current-voltage relationship (P < 0.05 for currents at membrane potentials between −20 and 
+100 mV).
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Fig. 5. KV1 channels regulate coronary vascular resistance at the resting heart rate
Coronary blood flow vs. the calculated intracoronary plasma concentration of correolide is 
shown. Error bars in the x direction represent variability in the calculated plasma 
concentrations due to changes in coronary blood flow, as the infusion rate of drug was held 
constant. Results are from n = 5 pigs in the vehicle group and n = 5 pigs in the correolide-
treated group. Daggers indicate the significant effect of vehicle (diluted DMSO) to cause 
coronary vasodilation (i.e., on average, vehicle alone increased coronary blood flow 0.18 
ml/min/g). Asterisks indicate significant correolide-induced coronary vasoconstriction at a 
constant perfusion pressure of 100 mm Hg.
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Fig. 6. KV1 channels function in coronary metabolic vasodilation
Panel A illustrates the relationship between coronary blood flow and myocardial oxygen 
consumption. Results are from n = 4 pigs in the vehicle group (5 pigs were tested, but all 
coronary venous blood samples from 1 pig were not collected due to a technical problem) 
and n = 5 pigs in the correolide-treated group. The rate of myocardial oxygen consumption 
was increased by infusing dobutamine at 4 increasing dose rates (Table 2). In vehicle-treated 
pigs, coronary blood flow increased linearly with the rate of myocardial oxygen 
consumption (filled symbols, solid line). In correolide-treated pigs (3 µM; open symbols, 
dashed line), the relationship between coronary blood flow and myocardial oxygen 
consumption was shifted down in a parallel manner (P < 0.001). Panel B shows the 
relationship between coronary venous PO2 and myocardial oxygen consumption. In the 
vehicle group, coronary venous PO2 fell as myocardial oxygen consumption increased. In 
the correolide-treated group, coronary venous PO2 was lower at rest and did not fall further 
as myocardial oxygen consumption increased. The regression lines are not parallel and 
different (P < 0.01).
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Fig. 7. KV1 channels participate in ischemic coronary vasodilation: reactive hyperemia
Coronary blood flow over time is shown: before, during, and after a 15 s occlusion. Results 
are from n = 5 pigs in the vehicle group (grey filled) and n = 5 pigs in the correolide-treated 
group (3 µM; solid line). Correolide reduced coronary blood flow at rest and accelerated the 
decay of ischemic hyperemia. Peak hyperemia (i.e., maximal vasodilation) was unaffected 
by inhibition of KV1 channels.
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Table 1
Primers used for qPCR
Gene Primers (5' to 3') Length Amplicon Accession number
KCNA1 F TTACGAACTGGGTGAGGAGGC
R ACCGAGACGATGGCGATGAC
21
20
165 AB033207.1
KCNA2 F GGCAGCTAGAAGGCGTAGGG
R CCTCTGGGTCATAGGTGTCCTG
20
22
124 NM_001110418.1
KCNA3 F CAGCTTCGACGCCATCCT
R CCTCGCGGAACTTCTCCAT
18
19
137 XM_001924029.3
KCNA4 F GGAGGATGAGGGTTTTGTGAGG
R ACGGAGACGATGGCTATGCC
22
20
132 XM_005658133.1
KCNA5 F CGGAGGAAGAGGAGGGAGAT
R CCGAGATATTGATGAGGACGC
20
21
105 NM_001006593.2
KCNA6 F GCGCTCTGGAGTTCGTGTTGT
R GGAAGTCTCCCGCATCCTGTT
21
21
145 XM_003481699.2
KCNA7 F GATGACCCGTTCTTTGTGGTG
R CGAAGTAGGGCAGAATAGCCAC
21
22
148 XM_005664712.1
KCNA10 F ATCTGGCGGGAAAATCCG
R TGTCATTGGAGGGGAGCAGT
18
20
155 XM_003125855.1
GAPDH F TGGGAAACTGTGGCGTGAT
R AAGGCCATGCCAGTGAGC
19
18
123 AF017079.1
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